|
|
Article: MerLion Buys Combinature, Athelas In Three-Way Merger.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BioWorld International Correspondent
MerLion Pharmaceuticals Pte. Ltd. gained two new antibiotics that are about to enter the clinic, plus a platform for identifying novel anti-virulence molecules through its stock-based acquisition of Combinature Biopharm AG and Athelas SA.
The company also banked $25 million, which represents the first closing of a $30 million venture capital round led by Aravis Venture Associates AG, of Zurich, Switzerland, and Bio*One Capital Pte. Ltd., of Singapore.
The second closing is due before the year's end, and the enlarged entity is aiming for an initial public offering in Japan in two years.
"Nomura ...